[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336945-105":59,"doc-detail-336945-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","mhc-hammer-reveals-genetic-and-non-genetic-hla-disruption-in-cancer-evolution","MHC Hammer reveals genetic and non-genetic HLA disruption in cancer evolution","","MHC Hammer is a computational toolkit that quantifies major histocompatibility complex (MHC) loss of heterozygosity (LOH), allele-specific mutation, expression/repression, and alternative splicing of class I HLA genes. Using WES and RNA-seq across normal lung and breast tissue and cancer cohorts including TRACERx and TCGA, the study maps extensive variability in HLA allelic expression and widespread HLA alternative splicing. In lung adenocarcinoma, lung squamous cell carcinoma, and ER+ tumors, class I HLA transcriptional repression and tumor-enriched splicing are linked to immune evasion and tumor evolution, including metastasis-associated neoantigen differences in LUAD.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/mhc-hammer-reveals-genetic-and-non-genetic-hla-disruption-in-cancer-evolution/336945/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/mhc-hammer-reveals-genetic-and-non-genetic-hla-disruption-in-cancer-evolution/336945.png","ImageObject",300,407,{"name":92,"@type":93},"Skyler","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-10","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What does MHC Hammer measure in class I HLA genes?","Question",{"text":113,"@type":114},"MHC Hammer assesses allele-specific mutations, LOH, allele-specific expression repression, and allele-specific alternative splicing using WES and RNA-seq data.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What types of HLA disruptions are reported in normal lung and breast tissue?",{"text":118,"@type":114},"The study identifies extensive variability in HLA allelic expression and pervasive HLA alternative splicing in normal lung and breast tissue.",{"name":120,"@type":111,"acceptedAnswer":121},"How are HLA disruptions associated with cancer evolution and metastasis?",{"text":122,"@type":114},"In LUAD, HLA LOH is associated with metastasis, and LUAD primary tumor regions that seed metastases show a lower effective neoantigen burden than non-seeding regions.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},336945,1790260994,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},2336464648746,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","nature genetics  \nArticle [https://doi.org/10.1038/s41588-024-01883-8](https://doi.org/10.1038/s41588-024-01883-8)  \nMHC Hammer reveals genetic and non-genetic HLA disruption in cancer evolution  \nReceived: 16 December 2022  \nAccepted: 25 July 2024  \n\n| Published online: 2 October 2024 |\n| --- |\n|  Check for updates |\n\nClare Puttick  1,2,3, Thomas P. Jones  2,3, Michelle M. Leung  1,2,3,  \nFelipe Galvez-Cancino  3,4,114, Jiali Liu  4, Manuel Varas-Godoy  5,6, Andrew Rowan1, Oriol Pich  1,3, Carlos Martinez-Ruiz  1,2,3, Robert Bentham2,3, Krijn K. Dijkstra1,3,7,8, James R. M. Black  1,2,3, Rachel Rosenthal1,  \nNnennaya Kanu  3, Kevin Litchfield  9, Roberto Salgado  10,11,  \nDavidA. Moore  1,3,12, Peter Van Loo  13,14,15, Mariam Jamal-Hanjani3,16,17, Sergio A. Quezada  3,4, TRACERx Consortium*, Charles Swanton  1,2,17  & Nicholas McGranahan  2,3   \nDisruption of the class I human leukocyte antigen (HLA) molecules has important implications for immune evasion and tumor evolution. We developed major histocompatibility complex loss of heterozygosity (LOH), allele-specific mutation and measurement of expression and repression (MHC Hammer). We identified extensive variability inHLA allelic expression and pervasive HLA alternative splicing in normal lung and breast tissue. In lung TRACERxand lung and breast TCGA cohorts, 61% of lung adenocarcinoma (LUAD), 76% of lungsquamous cell carcinoma (LUSC) and 35% of estrogen receptor-positive (ER+) cancers harbored class IHLA transcriptional repression, while HLA tumor-enriched alternative splicing occurred in 31%, 11% and 15% ofLUAD, LUSCandER+ cancers. Consistent with the importance of HLA dysfunction in tumor evolution, in LUADs, HLALOH was associated with metastasis and LUAD primary tumor regions seeding a metastasis hada lower effective neoantigen burden than non-seeding regions. These data highlight the extent and importance of HLA transcriptomic disruption, including repression and alternative splicing in cancer evolution.  \nEmerging data have highlighted the importance of considering cancer evolution in the context of a predatory immune microenvironment1–3. Key mediators ofthe cytotoxic T cell response in cancer are neoantigens, cancer-cell-specific alterations resulting in mutant peptides capable of eliciting a T cell-mediated, human leukocyte antigen (HLA)-restricted immune response. A mutation can only result in aneoantigen if the associated mutant peptide is presented onHLAmolecules totheT cell receptor. Therefore, disruption of HLA molecules has important implications for immune evasion.  \nDisruption to antigen-presenting machinery occurs across many cancer types4–7. Our previous work has revealed that HLA loss of heterozygosity (LOH), whereby one allele is somatically lost, occurs in 40% of non-small cell lung cancer (NSCLC) primary tumors7. A pan-cancer study has suggested that transcriptomicdownregulation of HLA genes occurs frequently4. However, subtle transcriptomic alterations, such as alternative splicing events and allele-specific repression, have been poorly studied in cancer. Alternative splicing, which has been reported in non-cancer tissue and cancer cell lines, can result ina non-functional  \nA full list of affiliations appears at the end of the paper. *A list of authors and their affiliations appears at the end of the paper.  \n[e-mail:](e-mail: charles.swanton@crick.ac.uk)[ charles.swanton@crick.ac.uk](e-mail: charles.swanton@crick.ac.uk); [nicholas.mcgranahan.10@ucl.ac.uk](nicholas.mcgranahan.10@ucl.ac.uk)  \nHLA genomic disruption  \nHLA transcriptomic disruption  \nFig. 1 | MHC Hammer: a tool to evaluate HLADNA and RNA disruption. MHC Hammer assesses allelic mutations, LOH, allelic repression and allelic alternative splicing in the class IHLA genes from WESand RNA-seq data. tumor adj, tumor adjacent; WES, whole-exome sequencing; RNA-seq, RNA sequencing.  \nHLA molecule or, in the case of exon 5 skipping, soluble isoforms of the HLA molecule8–13. Furthermore, understan","cbCainymJYf2NDT0","https://ap.wps.com/l/cbCainymJYf2NDT0","pdf",3955497,28,"English","# Background\n## Antigen presentation and HLA dysfunction\n# Methods\n## MHC Hammer pipeline\n## Datasets and cohorts\n# Results\n## Genomic and transcriptomic HLA disruption\n## HLA allele-specific expression in normal tissue\n# Discussion\n## Implications for immune evasion and tumor evolution","[{\"question\":\"What does MHC Hammer measure in class I HLA genes?\",\"answer\":\"MHC Hammer assesses allele-specific mutations, LOH, allele-specific expression repression, and allele-specific alternative splicing using WES and RNA-seq data.\"},{\"question\":\"What types of HLA disruptions are reported in normal lung and breast tissue?\",\"answer\":\"The study identifies extensive variability in HLA allelic expression and pervasive HLA alternative splicing in normal lung and breast tissue.\"},{\"question\":\"How are HLA disruptions associated with cancer evolution and metastasis?\",\"answer\":\"In LUAD, HLA LOH is associated with metastasis, and LUAD primary tumor regions that seed metastases show a lower effective neoantigen burden than non-seeding regions.\"}]","MHC Hammer reveals genetic and non-genetic HLA disruption in cancer evolution | PDF",1790017169,71,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ee119742c6867f896d482c0dba7644f1.webp",983,1305,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/89506a1e6b5673cac154df47fad16ae4.webp",982,1304,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fca51bff96c9bbd43d5e386861c5c4f3.webp",981,1303,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c4c9a0cd702a02267d0e1a4df408904e.webp",980,1301]